Manus Bio has filed a notice of an exempt offering of securities to raise $22,286,250.00 in New Equity and Debt Financing.
According to filings with the U.S. Securities and Exchange Commission, Manus Bio is raising $22,286,250.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Ajikumar Parayil played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About Manus Bio
Manus Bio leverages rapid advances in biology to produce complex natural ingredients used in our daily lives as flavors, fragrances, food ingredients, cosmetics, vitamins, pharmaceuticals, and agricultural chemicals. Using its advanced fermentation technology, Manus Bio recreates natural processes for next-generation industrial biomanufacturing and provides sustainable, cost-effective sources of ingredients for health, wellness, and nutrition. We call it Biomanufacturing Redefined.
To learn more about Manus Bio, visit http://www.manusbio.com/
Contact:
Ajikumar Parayil, Chief Executive Officer
617-299-8466
https://www.linkedin.com/in/ajikumar-parayil-96374a7/
SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.